[(3,5-DICHLOROPHENYL)METHYL]SULFONYL CHLORIDE, 95.0%, 5g

Dietilamina, mínimo 99,5 %, para síntesis, 100 ml, envase de vidrio

3-(tert-Butyl)-1-(4-methoxyphenyl)-1H-pyrazol-5-amine, 95.0%, 2g

N-[4-(2-Benzimidazolyl)phenyl]maleimide>98.0%(HPLC)(T)50mg

(2S,4R)-4-(Benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 25g

3-Nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 5g

2-(6-fluoro-1H-benzimidazol-2-yl)ethanol, 95.0%, 10g

4-(((3-chlorophenyl)sulfonamido)methyl)benzoic acid, 95.0%, 250mg

1-Piperazinecarboxylic acid, 3-(cyanomethyl)-, phenylmethyl ester, (3R)-, 98%, 1g

6'-(3-Pyridinyl)-3,2':4',4''-terpyridine, 100mg

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(3-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol, 98%, 1g

1-(2-methoxybenzoyl)-1,4-diazepane, 95.0%, 1g

5-Phenyl-1H-indole, 95.0%, 1g